Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2020-10-01 | 2020-11-07 | 125473 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2020-01-17 | 2020-08-21 | 103510 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-06-07 | 2024-11-01 | 229948 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-05-10 | 2018-02-21 | 9799 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2021-04-21 | 2021-05-13 | 137893 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2025-03-06 | 2025-03-20 | 252053 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2020-05-21 | 2020-08-21 | 115550 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163927 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2017-04-03 | 2018-02-21 | 5219 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2017-05-23 | 2018-02-21 | 10896 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-05-23 | 2018-02-21 | 10899 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-05-20 | 2021-08-13 | 139737 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-12-22 | 2023-02-09 | 179294 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2019-08-22 | 2019-11-08 | 92209 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-03-13 | 2018-03-13 | 1787 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-03-13 | 2017-12-16 | 1784 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2019-08-22 | 2020-01-17 | 92215 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161964 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-05-09 | 2024-10-17 | 227468 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-05-19 | 2022-12-22 | 161003 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Discontinued | 2025-10-22 | 2025-10-22 | 257579 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 |